TELL ME MORE
ABOUT THIS CLINICAL TRIAL for an INFANT MENINGOCOCCAL VACCINE
This is an Immunogenicity and Safety Study of a Quadrivalent Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants age 42 – 89 days old
Infant Meningococcal Vaccine
Study Location(s): Evansville Indiana
This study evaluates the safety and immunogenicity of a 4-dose series of the quadrivalent Meningococcal Polysaccharide (Serogroups A, C, Y, and W) in healthy infants and toddlers in comparison to MENVEO® when both are administered concomitantly with routine pediatric vaccines. Click here for more information on Meningococcal vaccines.
There is no cost to participate. Volunteers receive free vaccines and follow-up care. No insurance needed. Time and travel reimburrsement up to $400 may be available.
Watch a 2-minute video about Infant Meningococcal Vaccine